These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 27344000)

  • 21. The Norwegian standardization of the MATRICS (Measurement and Treatment Research to Improve Cognition in Schizophrenia) Consensus Cognitive Battery.
    Mohn C; Sundet K; Rund BR
    J Clin Exp Neuropsychol; 2012; 34(6):667-77. PubMed ID: 22439943
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cognitive impairment in schizophrenia.
    Keefe RS; Harvey PD
    Handb Exp Pharmacol; 2012; (213):11-37. PubMed ID: 23027411
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cognitive improvement after treatment with second-generation antipsychotic medications in first-episode schizophrenia: is it a practice effect?
    Goldberg TE; Goldman RS; Burdick KE; Malhotra AK; Lencz T; Patel RC; Woerner MG; Schooler NR; Kane JM; Robinson DG
    Arch Gen Psychiatry; 2007 Oct; 64(10):1115-22. PubMed ID: 17909123
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Spatial working memory and problem solving in schizophrenia: the effect of symptom stabilization with atypical antipsychotic medication.
    Snyder PJ; Jackson CE; Piskulic D; Olver J; Norman T; Maruff P
    Psychiatry Res; 2008 Sep; 160(3):316-26. PubMed ID: 18579217
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Influence of Venus and Mars in the cognitive sky of schizophrenia. Results from the first-step national FACE-SZ cohort.
    Fond G; Boyer L; Leboyer M; Godin O; Llorca PM; Andrianarisoa M; Berna F; Brunel L; Aouizerate B; Capdevielle D; Chereau I; D'Amato T; Dubertret C; Dubreucq J; Faget C; Gabayet F; Mallet J; Misdrahi D; Rey R; Lancon C; Passerieux C; Roux P; Vidailhet P; Yazbek H; Schürhoff F; Bulzacka E;
    Schizophr Res; 2018 May; 195():357-365. PubMed ID: 28974404
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Computer-assisted cognitive remediation in schizophrenia: what is the active ingredient?
    Kurtz MM; Seltzer JC; Shagan DS; Thime WR; Wexler BE
    Schizophr Res; 2007 Jan; 89(1-3):251-60. PubMed ID: 17070671
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Do sex differences affect prefrontal cortex associated cognition in schizophrenia?
    Roesch-Ely D; Hornberger E; Weiland S; Hornstein C; Parzer P; Thomas C; Weisbrod M
    Schizophr Res; 2009 Feb; 107(2-3):255-61. PubMed ID: 19004617
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association of White Matter With Core Cognitive Deficits in Patients With Schizophrenia.
    Kochunov P; Coyle TR; Rowland LM; Jahanshad N; Thompson PM; Kelly S; Du X; Sampath H; Bruce H; Chiappelli J; Ryan M; Fisseha F; Savransky A; Adhikari B; Chen S; Paciga SA; Whelan CD; Xie Z; Hyde CL; Chen X; Schubert CR; O'Donnell P; Hong LE
    JAMA Psychiatry; 2017 Sep; 74(9):958-966. PubMed ID: 28768312
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sex differences in neuropsychological performance and social functioning in schizophrenia and bipolar disorder.
    Vaskinn A; Sundet K; Simonsen C; Hellvin T; Melle I; Andreassen OA
    Neuropsychology; 2011 Jul; 25(4):499-510. PubMed ID: 21463042
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The NEWMEDS rodent touchscreen test battery for cognition relevant to schizophrenia.
    Hvoslef-Eide M; Mar AC; Nilsson SR; Alsiö J; Heath CJ; Saksida LM; Robbins TW; Bussey TJ
    Psychopharmacology (Berl); 2015 Nov; 232(21-22):3853-72. PubMed ID: 26202612
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Subjective cognition in schizophrenia].
    Potvin S; Aubin G; Stip E
    Encephale; 2017 Feb; 43(1):15-20. PubMed ID: 26923995
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A randomized, controlled trial of computer-assisted cognitive remediation for schizophrenia.
    d'Amato T; Bation R; Cochet A; Jalenques I; Galland F; Giraud-Baro E; Pacaud-Troncin M; Augier-Astolfi F; Llorca PM; Saoud M; Brunelin J
    Schizophr Res; 2011 Feb; 125(2-3):284-90. PubMed ID: 21094025
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sex differences in neuropsychological functioning among schizophrenia patients.
    Bozikas VP; Kosmidis MH; Peltekis A; Giannakou M; Nimatoudis I; Karavatos A; Fokas K; Garyfallos G
    Aust N Z J Psychiatry; 2010 Apr; 44(4):333-41. PubMed ID: 20050721
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effects of clozapine on cognitive functioning in schizophrenia.
    McGurk SR
    J Clin Psychiatry; 1999; 60 Suppl 12():24-9. PubMed ID: 10372607
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cognitive impairment associated with schizophrenia: a review of the humanistic burden.
    Kitchen H; Rofail D; Heron L; Sacco P
    Adv Ther; 2012 Feb; 29(2):148-62. PubMed ID: 22351433
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serum testosterone levels are related to cognitive function in men with schizophrenia.
    Moore L; Kyaw M; Vercammen A; Lenroot R; Kulkarni J; Curtis J; O'Donnell M; Carr VJ; Shannon Weickert C; Weickert TW
    Psychoneuroendocrinology; 2013 Sep; 38(9):1717-28. PubMed ID: 23490072
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cognitive neuroscience-based approaches to measuring and improving treatment effects on cognition in schizophrenia: the CNTRICS initiative.
    Carter CS; Barch DM
    Schizophr Bull; 2007 Sep; 33(5):1131-7. PubMed ID: 17630405
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Behavioral animal models to assess pro-cognitive treatments for schizophrenia.
    Young JW; Amitai N; Geyer MA
    Handb Exp Pharmacol; 2012; (213):39-79. PubMed ID: 23027412
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gender differences in cognitive function of patients with chronic schizophrenia.
    Han M; Huang XF; Chen DC; Xiu MH; Hui L; Liu H; Kosten TR; Zhang XY
    Prog Neuropsychopharmacol Biol Psychiatry; 2012 Dec; 39(2):358-63. PubMed ID: 22820676
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sex-specific differences in cognitive functioning among schizophrenic patients.
    Krysta K; Murawiec S; Klasik A; Wiglusz MS; Krupka-Matuszczyk I
    Psychiatr Danub; 2013 Sep; 25 Suppl 2():S244-6. PubMed ID: 23995185
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.